Weekly contraception with mifepristone

Contraception

Volumn 75, Issue 1, 2007, Pages 40-44

  Pei, Kaiyan ^a   Xiao, Bilian ^a   Jing, Xiaoping ^b   Lu, Shengqun ^c   Wei, Ling ^b   Zhao, Heng ^a  

^a NATIONAL RESEARCH INSTITUTE FOR FAMILY PLANNING   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c INNER MONGOLIA MEDICAL COLLEGE   (China)

Author keywords

Efficacy; Menstrual patterns; Mifepristone; Side effects; Weekly contraception

Indexed keywords

MIFEPRISTONE; PLACEBO;

ABDOMINAL PAIN; ADULT; ARTICLE; BREAST ENGORGEMENT; CHINA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED HEADACHE; FATIGUE; FEMALE; HUMAN; MENSTRUAL CYCLE; MENSTRUATION; NAUSEA; NORMAL HUMAN; ORAL CONTRACEPTION; OUTCOMES RESEARCH; PREGNANCY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; VOMITING;

ADULT; CONTRACEPTIVES, ORAL, SYNTHETIC; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MENSTRUATION; MIFEPRISTONE; NAUSEA;

EID: 33845223013     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2006.08.013     Document Type: Article

References (12)

1. Marions L., Danielsson K.G., Swahn M.L., et al. Contraceptive efficacy of low doses of mifepristone. Fertil Steril 70 (1998) 813-816
2. Cheng J., Weng L., Han X., and Xiao B. Study on weekly low doses of mifepristone for contraception. Zhonghua Fu Chan Ke Za Zhi 36 (2001) 424-427 [Chinese]
3. Godfrey E.M., Mawson J.T., Stanwood N.L., Fielding S.L., and Schaff E.A. Low-dose mifepristone for contraception: a weekly versus planned postcoital randomized pilot study. Contraception 70 (2004) 41-46
4. Chen X., and Xiao B. Effect of once weekly administration of mifepristone on ovarian function in normal women. Contraception 56 (1997) 175-180
5. Spitz I.M., Croxatto H.B., Salvatierra A.M., and Heikinheimo O. Response to intermittent RU486 in women. Fertil Steril 59 (1993) 971-975
6. Danforth D.R., Williams R.F., Hsiu J.G., et al. Intermittent GnRH antagonist plus progestin contraception conserving tonic ovarian estrogen secretion and reducing progestin exposure. Contraception 41 (1990) 623-631
7. Singh M.M. Centchroman, a selective estrogen receptor modulator, as a contraceptive and for the management of hormone-related clinical disorders. Med Res Rev 21 (2001) 302-347
8. Lal J., Nitynand S., Asthana O.P., Nagaraja N.V., and Gupta R.C. Optimization of contraceptive dosage regimen of Centchroman. Contraception 63 (2001) 47-51
9. Potter L., Oakley D., de Leon-Wong E., and Canamar R. Measuring compliance among oral contraceptive users. Fam Plann Perspect 28 (1996) 154-158
10. David S.S., Huggins G.R., Garcia C.R., and Busacca C. A synthetic steroid (R2323) as a once-a-week oral contraceptive. Fertil Steril 31 (1979) 278-281
11. Bartl R., Gotte S., Hadji P., and Hammerschmidt T. Adherence with daily and weekly administration of oral bisphosphonates for osteoporosis treatment. Dtsch Med Wochenschr 131 (2006) 1257-1262
12. Recker R.R., Gallagher R., and MacCosbe P.E. Effect of dosing frequency on bisphosphonate medication adherence in a large longitudinal cohort of women. Mayo Clin Proc 80 (2005) 856-861